Acutus Medical Inc
AFIB
AFIB was delisted on the 8th of May, 2024.
35 hedge funds and large institutions have $8.13M invested in Acutus Medical Inc in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
2,400% more call options, than puts
Call options by funds: $25K | Put options by funds: $1K
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
17% more capital invested
Capital invested by funds: $6.96M → $8.13M (+$1.17M)
8% less funds holding
Funds holding: 38 → 35 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$91.8K |
| 2 |
Millennium Management
New York
|
+$19.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13.5K |
| 4 |
Squarepoint
New York
|
+$12.1K |
| 5 |
DM
Deerfield Management
New York
|
+$7.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$135K |
| 2 |
Renaissance Technologies
New York
|
-$21.1K |
| 3 |
VF
Virtu Financial
New York
|
-$18K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.4K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
-$5.2K |
AFIB Hedge Fund Activity: Q2 2023 in Review
35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q2 2023, worth a combined $8.13M — up 17% from $6.96M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AFIB and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Parkman Healthcare Partners, adding an estimated $91.8K. The largest seller was Kamunting Street Capital Management, exiting entirely with an estimated $135K sold.
- 35 institutional investors held Acutus Medical Inc (AFIB) as of Q2 2023, down from 38 in Q1 2023.
- Funds reported $8.13M of Acutus Medical Inc stock for Q2 2023, up 17% quarter-over-quarter.
- 3 funds opened new Acutus Medical Inc positions in Q2 2023 and 6 closed out, a net change of -3 holders.
- The largest Acutus Medical Inc buyer in Q2 2023 was Parkman Healthcare Partners, an estimated $91.8K added.
- The largest Acutus Medical Inc seller in Q2 2023 was Kamunting Street Capital Management, an estimated $135K sold.
Based on aggregated 13F filings for Q2 2023.